Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIGEST CP: ALTU-135 in Exocrine Pancreatic Insufficiency
NCT00500084Phase 3Terminated
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Dec 2007
- Primary completion
- Mar 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of liprotamase in exocrine pancreatic insufficiency (EPI), sponsored by Anthera Pharmaceuticals, Inc.. Started Dec 2007; status: terminated.
02
Drugs
liprotamase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00500084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500084.